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Key points
 Phosphorylation at Ser-2808 is suggested to result in RyR2 hyperactivity, i.e. ‘leakiness’, thus
contributing to the pathology of cardiac diseases.
 We studied the effect of disabling phosphorylation at Ser-2808 of RyR2 in a genetic model of
Ca2+-dependent cardiomyopathy, which was caused by leaky RyR2.
 RyR2 phosphorylation was high at Ser-2808 in myocytes expressing wild-type (WT) RyR2;
protein phosphatase increased RyR2 leakiness in cells expressingWT, but not in mutant RyR2s
with disabled Ser-2808 phosphorylation sites.
 Rather than alleviating cardiac disease, ablation of the Ser-2808 exacerbated the disease
phenotype by reducing survival, impairing in vivo cardiac function and enhancing RyR2
Ca2+ leak and mitochondrial damage.
 These results suggest a novel mode of RyR2 regulation via dephosphorylation at Ser-2808 in
normal and diseased hearts.
Abstract Phosphorylation of the cardiac ryanodine receptor (RyR2) by protein kinase A (PKA)
at Ser-2808 is suggested to mediate the physiological ‘fight or flight’ response and contribute
to heart failure by rendering the sarcoplasmic reticulum (SR) leaky for Ca2+. In the present
study, we examined the potential role of RyR2 phosphorylation at Ser-2808 in the progression of
Ca2+-dependent cardiomyopathy (CCM) by using mice genetically modified to feature elevated
SR Ca2+ leak while expressing RyR2s that cannot be phosphorylated at this site (S2808A).
Surprisingly, rather than alleviating the disease phenotype, constitutive dephosphorylation of
Ser-2808 aggravated CCM as manifested by shortened survival, deteriorated in vivo cardiac
function, exacerbated SR Ca2+ leak and mitochondrial injury. Notably, the deteriorations of
cardiac function, myocyte Ca2+ handling, and mitochondria integrity were consistently worse in
mice with heterozygous ablation of Ser-2808 than in mice with complete ablation. Wild-type
(WT) and CCM myocytes expressing unmutated RyR2s exhibited a high level of baseline
phosphorylation at Ser-2808. Exposure of these CCM cells to protein phosphatase 1 caused a
transitory increase in Ca2+ leak attributable to partial dephosphorylation of RyR2 tetramers at
Ser-2808 from more fully phosphorylated state. Thus, exacerbated Ca2+ leak through partially
dephosphorylatedRyR2s accounts for the prevalence of the disease phenotype in the heterozygous
S2808A CCMmice. These results do not support the importance of RyR2 hyperphosphorylation
in Ca2+-dependent heart disease, and rather suggest roles for the opposite process, the RyR2
dephosphorylation at this residue in physiological and pathophysiological Ca2+ signalling.
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Introduction
Abnormal calcium (Ca2+) release from the sarcoplasmic
reticulum (SR) is recognized to play a key role in
pathological events in theheart. Evidence fromhumanand
animalmodels of disease suggests that the cardiac SRCa2+
release channel (RyR2) becomes abnormally active, i.e.
‘leaky’, in the failing heart (Marx et al. 2000; Shannon et al.
2003; Eisner et al. 2004; Kubalova et al. 2005). Accelerated
diastolic release is thought to contribute to heart failure
by compromising systolic Ca2+ release and contractility,
impairing diastolic relaxation, as well as by activating
pathological hypertrophic pathways and inducing cell
death (Molkentin, 2000; Backs & Olson, 2006; Bers et al.
2006; Heineke & Molkentin, 2006; Anderson et al. 2011).
Although the pathological role of increased diastolic
release via leaky RyR2s in heart failure has been well
established, themechanismsunderlyingRyR2dysfunction
remain controversial. Marks and colleagues have put forth
evidence that increased phosphorylation of the RyR2
homotetramer by protein kinase A (PKA) on Ser-2808
results in dissociation of FKBP12.6 from the RyR2
complex, causing RyR2s to become hyperactive (Marx
et al. 2000;Wehrens et al. 2006; Shan et al. 2010). However,
key facets of this hypothesis have been challenged by other
groups (Xiao et al. 2004; Carter et al. 2006; Benkusky
et al. 2007; Bers, 2012; Zhang et al. 2012; Fischer et al.
2013). A growing body of evidence suggests that rather
than PKA phosphorylation at Ser-2808, phosphorylation
by CaMKII at Ser-2814 contributes to HF by enhancing
RyR2 leak (Belevych et al. 2011; Respress et al. 2012;
Fischer et al. 2013). Further adding to the complexity of
the issue, RyR2 phosphorylation at these different sites
have been suggested to play different roles in ischaemic vs.
non-ischaemic cardiac disease (e.g. Ser-2808 vs. Ser-2814,
respectively; Wehrens et al. 2006; Respress et al. 2012).
Unlike other PKA phosphorylation target proteins
thought to be involved in the β-adrenergic modulation
of cardiac Ca2+ signalling, such as Ser-2030 of RyR2 and
Ser-16of phospholamban (PLB;Xiao et al.2005;Benkusky
et al.2007), Ser-2808 is highlyphosphorylated (>60–80%)
even at baseline (i.e. absence of adrenergic stimulation),
according to most reports (Carter et al. 2006; Xiao et al.
2006; Benkusky et al. 2007; Fischer et al. 2013). This
would substantially limit the functional responsiveness of
this site to PKA phosphorylation. Indeed, a number of
studies reported no discernible effects of PKA stimulation
on RyR2 Ca2+ release (Li et al. 2002; Stange et al. 2003;
Benkusky et al. 2007). Interestingly, previous work by
this group and others has shown that decreasing (rather
than increasing) RyR2 phosphorylation at this site by
exogenous phosphatases results in increased RyR2 activity
and enhanced diastolic SR Ca2+ release (Lokuta et al.
1995; Valdivia et al. 1995; Terentyev et al. 2003). These
controversial results further suggest that the role of RyR2
Ser-2808 phosphorylation ismore complex than currently
recognized. Thus, whether and howPKAphosphorylation
status of RyR2 affects RyR2 function and contributes to
degenerative cardiac disease requires further investigation.
Heart failure is associated with elevated plasma
catecholamines and increased β-adrenergic tone as part
of the compensatory response to decreased contractility
(Packer, 1988). Given the complex interplay between
Ca2+ homeostasis, β-adrenergic signalling, and heart
failure, it is difficult to dissect the specific contribution
of either pathway to the pathophysiology of this disease.
To examine the relationship between Ca2+ leakiness and
cardiac disease, we recently generated a mouse model
that reproduces constitutive elevated diastolic Ca2+ release
by combining deficiency in the expression of the RyR2
regulatory protein calsequestrin 2 (CASQ2) with over-
expression of SERCA1a. The double mutant (DM) mice
develop dilated cardiomyopathy and die prematurely of
contractile failure due tomitochondrial Ca2+ damage and
apoptosis, with severity of the phenotype dependent on
the extent of leakiness (Kalyanasundaram et al. 2012).
In the present study, we sought to examine the
potential role of RyR2 phosphorylation at Ser-2808 in
the development of Ca2+-dependent cardiomyopathy
(CCM) by using triple mutant (TM) mice featuring
elevated diastolic release while expressing RyR2s that
cannot be phosphorylated at this site (TM-S2808A).
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If phosphorylation of Ser-2808 indeed contributes to
disease by exacerbating SR Ca2+ leak, ablation of this site
would alleviate CCM. Rather than alleviating the disease
phenotype, constitutive dephosphorylation of Ser-2808
markedly aggravated CCM. These results suggest a novel
mode of regulation of RyR2, in which dephosphorylation
from a highly phosphorylated state (rather than further
phosphorylation) increases RyR2 activity.
Methods
Ethical approval
All animal procedures were approved by The Ohio State
University Institutional Animal Care and Use Committee.
The study conformed to the Guide for the Care and
Use of Laboratory Animals published by the US National
Institutes of Health (NIH Publication No. 85–23, revised
1996). The authors have read, and the experiments comply
with, the policies and regulations of The Journal of Physio-
logy given by Drummond (1996).
Generation of triple mutant mouse models
Previously, a double mutant mouse model of Ca2+-
dependent cardiomyopathy was generated by cross-
breeding the CASQ2 knockout (KO) mice with mice
overexpressing SERCA1a (Kalyanasundaram et al. 2012).
The double mutant mice (CASQ2+/−-SERCA1aox) of
mixed strain on a predominantly FVB/N background,
were further crossbred with RyR2 S2808A mice (Sv129)
(Benkusky et al. 2007; Ullrich et al. 2012) to obtain
triple mutant mice. The genotypes of the crossbred mice
were confirmed by polymerase chain reactions (PCR;
for CASQ2 KO, SERCA1a overexpression, RyR2 S2808A
mutation) using tail DNA. The detailed breeding scheme
is shown in Fig. 1. Age- and litter- controlled mice
were utilized for experiments. Since survival of DM mice
was similar between males and females, animals of both
genders were used in the study. Of note, the sex and
strain backgrounds of the animals differ from our pre-
vious work (Kalyanasundaram et al. 2012), where only
males were used (DM females exhibited longer survival,
unpublished observation). To simplify the nomenclature
of the genetically engineered mice involved in this study,
the term mutant (as in double mutant, DM, or triple
mutant, TM) is used as a generic term to include both
transgenic and targetedmutant (knock-in and knock-out)
mice.
Transthoracic echocardiography
Mice were lightly anaesthetized using 1% isoflurane in
95% oxygen. The body temperature of the mice was
maintained at 37°C by a heating pad. In vivo cardiac
function was assessed at different time points using a
Visualsonic Vevo 2100 imaging system, with a 30 MHz
probe (VisualSonics, Toronto, Canada).Datawas analysed
using VisualSonic Software.
Electrocardiographic Recordings
Mice were lightly anaesthetized using 1.5% isoflurane
in 95% oxygen. Baseline ECG was recorded for 5 min,
followed by an additional 25 min after administration of
β-agonist isoproterenol (ISO, 1.5 mg kg−1, I.P. injection).
Response to toe-pinch reflex was examined to ensure the
proper level of anaesthesia.
Cardiomyocyte isolation and confocal Ca2+ imaging
Myocyte isolation. Mouse ventricular myocytes were
isolated as previously described (Gyorke et al. 1997).
Briefly, hearts were quickly excised and perfused on a
Langendorff’s apparatus at 37°C. After5 min perfusion
with nominally Ca2+-free Tyrode solution (containing,
in mM: 140 NaCl, 5.4 KCl 0.5 MgCl2, 10 Hepes and
5.6 glucose; pH 7.3), the perfusate was then switched to
Tyrode solution containing Liberase Blendzymes (Roche,
Applied Science, IN, USA) for digestion of the connective
tissue. After 20 min digestion, single ventricular myo-
cytes were isolated fromdissected and triturated ventricles
and stabilized in BSA containing Tyrode solution.
Ca2+ imaging. Ventricular myocytes were loaded with
8 μM Fluo 3 AM (Invitrogen, Carlsbad, CA, USA) for
25 min at room temperature (RT), followed by 25 min
incubation at RT to allow the fluorescent dye to wash
out, and deesterification. Fluo 3 was excited with the
488 nm line of an argon laser and emissionwas collected at
500–600 nm. Fluo 3 fluorescence was recorded in the line
scanmodeof the confocalmicroscope (Olympus Fluoview
1000). Myocytes were paced at 0.5 Hz using extracellular
platinum electrodes. To assess the SR Ca2+ load, 20 mM
caffeine was applied at the end of the experiments. Fluo 4
pento potassium salt (Invitrogen) was used to record Ca2+
sparks. The myocytes were permeabilized with saponin
(0.01% for 30 s) dissolved in the internal solution,
which contained (mM): 120 potassium aspartate, 20 KCl,
0.81 MgCl2, 1 KH2PO4, 0.5 EGTA, (free [Ca2+] 50 nM),
3 MgATP, 10 phosphocreatine, 20 Hepes (pH 7.2) and
5 U ml−1 creatine phosphokinase.
Mitochondrial membrane potential measurement
A voltage-sensitive fluorescent indicator, tetramethyl-
rhodamine ethyl ester (TMRE) was utilized to measure
mitochondria membrane potential. Freshly isolated
mouse ventricular myocytes were loaded with TMRE
(75 nM, 20min, 37°C). TMREwas excited at 543 nmwith a
helium–neon laser, and the emission signals were collected
at 570–650 nm. TMRE fluorescence was measured as a
series of X–Y confocal images.
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To quantify the level of regional mitochondria damage,
the areas devoid of mitochondrial staining were auto-
matically labelled using a custom-written MATLAB
program (See Fig. 10A). The program first rotated the
confocal image so that the longitudinal direction of the cell
was oriented vertically. Then the horizontal edges between
the stained and non-stained areas were identified using
image convolution with a Sobel operator. The algorithm
then paired two edges if there was no staining between
them. Finally, the area between the paired edges was
measured andwas considered as damaged region if its area
was larger than the size of 15 pixels. The individual size
and number of such regionswere quantified, summarized,
and compared among groups.
Western blots
Mouse ventricular homogenates were prepared as
previously described (Jaehnig et al. 2006). Proteins
were separated by SDS–PAGE (5%–15% gradient gel,
Bio-rad) and transferred onto nitrocellulose membrane.
Membranes were probed by primary antibodies against
RyR2 (Thermo Scientific) and Ser-2808 phosphorylated
RyR2 (Badrilla Ltd), followed by secondary anti-mouse
or anti-rabbit antibodies. SuperSignal chemiluminescence
(PierceBiotechnology Inc, Rockford, IL,USA)wasutilized
to detect the horseradish peroxidase conjugated protein
bands. ImageJ was utilized to quantify the protein
expression levels.
[3H]Ryanodine binding assay
[3H]Ryanodinebinding assaywasperformedaspreviously
described with modifications (Li & Chen, 2001). The
Ca2+-dependent [3H]ryanodine binding was determined
with cardiac homogenates plus a standard mixture of
200 mM KCl, 25 mM Tris–50 mM Hepes (pH 7.4),
3 mM MgATP, 1 mM EGTA, 5 nM [3H]ryanodine
(68.4 Ci mmol−1, Dupont NEN, Wilmington, DE, USA)
and CaCl2. Free Ca2+ concentration was set from pCa 8 to
pCa 3 by using MaxChelator (http://www.stanford.edu/
cpatton/maxc.html). [3H]ryanodine binding was nor-
malized to RyR2 expression level which was determined
by Western blots.
Transmission electron microscopy (TEM)
Mouse hearts were excised from the chest and dissected
into thin slices. Left ventricular tissue was cut into 1 mm
cube and immediately put it into a puddle of fixative on a
wax plate. The fixative consists of 2.5% glutaraldehyde in
0.1 M phosphate buffer, pH 7.4. The tissue was fixed over-
night at 4°C.The tissuewas further processed as previously
described (Fraysse et al. 2010).Ultra-thin sections (70 nm)
were produced on a Leica EM UC6 ultramicrostome and
stained with 2% uranyl acetate and Reynold’s lead citrate.
TEM was performed on a FEI Tecnai G2 Spirit TEM at
80 kV. Images were captured using an AMT 2 ×2 digital
camera.
Materials
Protein phosphatase 1 (PP1) was purchased from Sigma
(St Louis, MO, USA). Fluorescent dyes were purchased
from Invitrogen (Carlsbad, CA, USA).
Statistical analysis
Results are expressed as means ± SEM. Statistical
significance of differences between experimental groups
was determined using unpaired Student’s t test. A value of
P < 0.05 was considered statistically significant.
Results
Ablation of RyR2 phosphorylation at Ser-2808
increased mortality in CCM
To investigate the role of PKA phosphorylation of RyR2
in Ca2+-dependent cardiomyopathy (CCM), we cross-
bred double mutant (DM) mice deficient in CASQ2 and
expressing SERCA1awithmice in which Ser-2808 of RyR2
was replaced with Ala to prevent phosphorylation at this
site. The crossing gave rise to triple mutant (TM) mice
that were deficient in expression of CASQ2, overexpressed
SERCA1a, and expressed RyR2s that had the Ser-2808 site
either partially or completely disabled (TM-S2808A+/−
andTM-S2808A+/+, respectively; Fig. 1). In linewith our
previous observations (Kalyanasundaram et al. 2012),DM
mice (CASQ2+/−-SERCA1aox) exhibited shorter survival
than WT controls (albeit to a lesser extent than in the
previous study). Disabling the Ser-2808 site increased
the death rate in the TM mice. Surprisingly, early
death was more pronounced in mice with heterozygous
(TM-S2808A+/−), than with homozygous ablation of
the Ser-2808 phosphorylation site (TM-S2808A+/+)
(Fig. 2A). Thus, the survival studies showed that genetic
disabling of PKA phosphorylation at Ser-2808 did not
improve survival of CCM mice. Instead, ablation of the
Ser-2808 site exacerbated mortality, most notably in TM
mice heterozygous for S2808A.
Of note, the crossbreeding between DM and
S2808A+/+ mice gave rise to a spectrum of mice with
various genotypes. All the relevant control groups for this
study, including DM controls, were littermates obtained
from the crossbreeding to ensure validity of comparison.
Ablation of RyR2 phosphorylation at Ser-2808
exacerbated in vivo cardiac dysfunction in CCM but
did not exacerbate arrhythmia vulnerability
Consistent with previous demonstration of structural
remodelling in Ca2+-dependent cardiomyopathy (Kalya-
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nasundaram et al. 2012), postmortem examination
showed elevated heart weight/body weight ratio
(HW/BW) in DM mice. Ablation of Ser-2808 rather
than preventing hypertrophy led to a further increase of
HW/BW, especially in theTM-S2808A+/−mice (Fig. 2B).
We next examined in vivo cardiac function and chamber
dimensions by echocardiography in the four different
mouse groups (Fig. 2C and D). At the age of 2 months,
when DM mice only began to show signs of depressed
ejection fraction (EF), EF was already markedly reduced
in TM-S2808A+/− compared with wild type (WT) mice
(39.8 ± 4.0 vs. 61.6 ± 1.4, P < 0.05, Fig. 2C), although
not as much in TM-S2808A+/+ mice. Additionally,
left ventricular end-systolic dimension (LVESD) was
significantly increased in TM-S2808A+/− mice, but only
tended to increase in TM-S2808A+/+ mice (Fig. 2C).
Surface electrocardiography (ECG) was recorded
from lightly anaesthetized mice before and after
catecholaminergic challenge with isoproterenol (ISO).
At baseline, all groups showed a nearly normal sinus
rhythm. With a catecholamine challenge (1.5 mg kg−1,
ISO), ventricular tachycardia was observed in one-third
of mice from all three CCM groups, but not in the
WT group (Fig. 3). Taken together, these results suggest
that heterozygous ablation of Ser-2808 phosphorylation
exacerbated contractile dysfunction, but did not seem to
exacerbate arrhythmogenic propensity in our model.
Ablation of RyR2 phosphorylation at Ser-2808
exacerbated abnormal Ca2+ handling in CCM
Confocal Ca2+ imaging was performed in myocytes iso-
lated from the same four mouse groups (WT, DM,
TM-S2808A+/− and TM-S2808A+/+). At baseline,
consistent with our previous studies (Kalyanasundaram
et al. 2012), the DM myocytes displayed increased Ca2+
transient amplitude and increased frequency of diastolic
Ca2+ waves compared to WT myocytes (Fig. 4). The
frequency of Ca2+ waves was further increased in both
TM groups, with the change being more pronounced
in TM-S2808A+/− myocytes (Fig. 4B). The SR Ca2+
content was markedly increased in all three CCM groups
(DM, TM-S2808A+/− and TM-S2808A+/+), with no
significant differences between the groups (Fig. 4D). ISO
further increased the frequency of Ca2+ waves in each
group, with both TM-S2808A+/− and TM-S2808A+/+
myocytes displaying higher wave frequencies than DM
myocytes (Fig. 4B). Of note, ISO did not further increase
the SRCa2+ content in the three CCMgroups, as evidently
maximum attainable SR Ca2+ content in these cells was
already reached due to the activity of overexpressed
SERCA1a. The ability of ISO to increase Ca2+ wave
frequency in the TM cells expressing RyR2 that cannot be
phosphorylated at Ser-2808 suggests that ISO-dependent
Ca2+ waves are mediated by phosphorylation of sites
distinct from Ser-2808, most likely the CaMKII site,
Ser-2814, as suggested by several previous studies (Ferrero
et al. 2007; Curran et al. 2010; Pereira et al. 2013), and
possibly RyR2 oxidation, which has also been shown to
increase upon stimulation with ISO (Bovo et al. 2012).
Additionally Chen et al (Xiao et al. 2005, 2007) reported
that PKA-dependent phosphorylation ofRyR2 at Ser-2030
can increase RyR2 functional activity by modulating
RyR2’s sensitivity to luminal Ca2+ (Xiao et al. 2007).
Thus the mechanisms of Ser-2808-independent effects of
adrenergic stimulation remain to be clarified.
Rather than manifesting a direct modulatory influence,
the observed effects of ablation of the Ser-2808 site
on Ca2+ handling in CCM mice could result from
RyR2 dysregulation due to lack of CASQ2. To examine
this possibility, we performed experiments in SERCA1a
Breeding scheme
CASQ2+/--SERCA1aox RyR2 S2808A+/+
(TM-S2808A+/-)(DM)
X
CASQ2+/--SERCA1aox-S2808A+/- CASQ2+/--SERCA1aox-S2808A+/+CASQ2+/--SERCA1aox
(TM-S2808A+/+)
WT
(DM)
Figure 1. Breeding scheme and nomenclature for the mice involved in current study
This figure lists the simplified breeding process for the triple mutant mice, which were deficient in expression of
CASQ2, overexpressed SERCA1a, and expressed RyR2s that had the Ser-2808 site either partially or completely
disabled. Additionally, the abbreviations for the different mutant mice and its associated genotype are listed. Of
note, the crossbreeding between the DM and RyR2 S2808A mice also gave rise to mice with other genotypes
which were not listed here. This breeding scheme is a simplified version listing only the relevant study groups.
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expressing mice carrying either WT or mutant RyR2
(S2808A), but normal for CASQ2. SERCA1a over-
expression results in healthy mice with enhanced cardiac
contractility, robustmyocyte SRCa2+ uptake and stable SR
Ca2+ load (Loukianov et al. 1998). Similar to our results in
the TM myocytes, ablation of Ser-2808 phosphorylation
resulted in increased frequencyofCa2+ sparks in SERCA1a
expressing myocytes (Fig. 5). Moreover, spark frequency
tended to be higher in S2808A+/– than S2808A+/+
group. Thus, ablation of Ser-2808 is capable of increasing
RyR2 activity independently of CASQ2 regulation of the
channel.
Ablation of Ser-2808 phosphorylation blunted the
increase in Ca2+ spark frequency by exogenous
phosphatases
Consistent with previous studies (Carter et al. 2006; Xiao
et al. 2006; Benkusky et al. 2007), RyR2 was highly
phosphorylated (75%) at Ser-2808 in WT and DM
hearts expressing unmutated RyR2s, while substitution
of Ser for Ala at 2808 rendered the sites either partially
dephosphorylated or non-phosphorylatable in the
TM-S2808A+/– or TM-S2808A+/+ group, respectively
(Fig. 6A and B). Given the high phosphorylation status
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Figure 2. Ablation of RyR2 phosphorylation at Ser-2808 exacerbated survival and in vivo cardiac
function in the CCM model
A, survival studies on DM mice and TM mice with Ser-2808 phosphorylation ablated. Sample sizes, indicated next
to the curves, included 9 males and 15 females for DM; 11 males and 14 females for TM-S2808A+/+ and 11
males and 13 females for TM-S2808A+/–. B, mean ± SEM of HW/BW. C, means ± SEM of LV ejection fraction
(EF%), left ventricular end-systolic dimension (LVESD) and left ventricular end-diastolic dimension (LVEDD) at the
age of 2 months. ∗P < 0.05 vs. WT control, #P < 0.05 vs. TM-S2808A+/−. Sample sizes are indicated within the
respective columns. D, representative images of M-mode echocardiography.
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of RyR2 at baseline, it is possible that dephosphorylation
(rather than further phosphorylation) of this site leads
to exacerbated CCM and abnormal Ca2+ cycling by
enhancingRyR2 leakiness inTMmice. Todirectly examine
the functional consequences of RyR2 dephosphorylation
at Ser-2808, we performed experiments with application
of the protein phosphatase PP1 to permeabilized
DM, TM-S2808A+/– and TM-S2808A+/+ myocytes.
Consistent with the notion that dephosphorylation
causes increased RyR2 leakiness, baseline spark frequency
was significantly higher in TM myocytes than in
DM myocytes. Interestingly, baseline frequency was
highest in TM-S2808A+/– myocytes with incomplete
dephosphorylation (Fig. 6C and D). Addition of PP1
(10 U ml−1) significantly increased spark frequency
measured within 30 s after PP1 application in DM cells
(Fig. 6C and D). Notably, the increase in spark frequency
in these cells was transient, despite overexpression of
SERCA1a which should preclude significant SR Ca2+
depletion in these myocytes. Since on addition of PP1,
phosphorylated RyR2s must initially pass through sets
of partially dephosphorylated states before becoming
completely dephosphorylated at all sites, these results
reaffirm that partial dephosphorylation of RyR2 at
Ser-2808 exacerbates RyR2 leakiness to a greater extent
than complete dephosphorylation. In further support of
this notion, addition of PP1 failed to produce a transient
increase of spark frequency in TM-S2808A+/− cells from
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Figure 3. Ablation of RyR2 phosphorylation at Ser-2808 did not further increase the arrhythmogenic
propensity in the Ca2+-dependent cardiomyopathy models
A, the number of mice displaying ventricular tachycardia (VT) was similar among all three cardiomyopathy groups
after catecholamine challenge (ISO, 1.5 mg kg−1 I.P.). B, representative traces of normal ECG (upper trace) and
ventricular tachycardia (lower trace).
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its elevated baseline level, but instead led to significant
decrease in steady-state Ca2+ spark frequency. PP1 failed
to increase Ca2+ spark frequency in TM-S2808A+/+
myocytes, in which all 2808 sites are constitutively
dephosphorylated (Fig. 6C and D). Taken together these
results suggest that (1) RyR2 dephosphorylation at
Ser-2808 enhances RyR2 leakiness and (2) the effects of
partial dephosphorylation on leak are greater than those
of complete dephosphorylation.
To further examine the effects of ablation of
Ser-2808 phosphorylation on RyR2 activity in our
CCM mouse models, we performed measurements
of [3H]ryanodine binding. Consistent with spark
measurements, [3H]ryanodine binding was significantly
increased in both TM groups, and more substantially in
TM-S2808A+/−, as compared with DM (Fig. 7).
Heterozygous ablation of RyR2 phosphorylation at
Ser-2808 increased Ca2+ signalling heterogeneity
Apart from increasing leakiness of individual RyR2s,
it is also possible that partial disruption of RyR2
phosphorylation by PKA plays a detrimental role by
increasing spatial heterogeneity of Ca2+ signalling in
cardiac myocytes. Assuming that WT and mutant
(S2808A) RyR2 monomers randomly mix to assemble
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Figure 5. Ablation of Ser-2808 phosphorylation also increased
SR Ca2+ leak in mice overexpressing SERCA1a
A, averaged spark frequency for mice with different genotypes for
the RyR2s. Data are means ± SEM from at least 15 cells from each
group. ∗P < 0.05 vs. SERCA1a-WT RyR2. B, representative line-scan
images of Ca2+ sparks in intact myocytes.
into a tetrameric channel, one would expect a sub-
stantial heterogeneity in the composition of individual
RyR2 tetramers, as well as in the composition of clusters
of RyR2 channels forming release sites. To look for
such possible spatial heterogeneities of Ca2+ signalling,
we examined Ca2+ spark amplitude characteristics in
permeabilized myocytes from the two triple trans-
genic groups. Notably, spark amplitude was significantly
increased in TM-S2808A+/− myocytes compared to
TM-S2808A+/+ (Fig. 8A and C). The difference in spark
amplitudes is further emphasized in Figs 8A and B which
show that the increase in Ca2+ spark amplitude was due to
the redistribution of Ca2+ sparks to a larger amplitude
population. Additionally, the mean standard deviation
(SD) of Ca2+ spark amplitude in the S2808A+/– group
was significantly larger than that of the S2808A+/+ group
(Fig. 8C), further suggestive of greater spark amplitude
heterogeneity in S2808A+/− myocytes.
Ablation of RyR2 phosphorylation at Ser-2808
exacerbated ultrastructural and regional
mitochondrial damage
Elevated diastolic SR Ca2+ release has been shown
to result in mitochondrial Ca2+ overload and injury,
in turn leading to myocyte degeneration and death
(Dorn, 2013). To examine whether deteriorated Ca2+
cycling in the TM myocytes is associated with increased
ultrastructural and regional mitochondrial damage,
we utilized electron microscopy (EM) and performed
mitochondrial membrane potential measurements using
tetramethylrhodamine ethyl ester (TMRE). As illustrated
by the EMmicrographs in Fig. 9, comparedwith the intact
mitochondria structure of WT mice, DM did not show
pronounced mitochondria damage, but both TM groups
had severe mitochondria damage marked by partial or
complete disruption of the mitochondria matrix. The
extent of such mitochondria damage was more severe
in the TM-S2808A+/– group than the TM-S2808A+/+
group (Fig. 9A andB).
Mitochondrial membrane potential measurements
revealed further pathological changes in mitochondria
associated with deteriorated Ca2+ handling in the TM
myocytes. As shown in Fig. 10, WT myocytes displayed
a relatively homogenous labelling, with organized
arrangement of mitochondria bands along the myofibrils.
However, such homogenous labelling was disrupted to
different degrees in the three CCM groups, which is
illustrated more clearly in the enlarged images shown in
Fig. 10A. Myocytes from the three CCM groups displayed
round areas of varying sizes devoid of mitochondrial
potential staining indicative of regional damage (Fig. 10A).
In TM-S2808A+/− myocytes, this ‘Swiss cheese’ pattern
was most pronounced. When quantified, the average size
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of regional damage (shown as holes in the TMRE staining
of myocytes, highlighted in green in the lower panels of
Fig. 10A) was significantly larger in the TM-S2808A+/−
group than in the other two groups.When the distribution
of hole size was plotted, the TM-S2808A+/− group also
outnumbered the other two groups at the large-size scale
(inset of Fig. 10B). Additionally, the size of mitochondria
regional damage is also more heterogeneous in the
TM-S2808A+/− group (Fig. 10C), supported by the
increased SD of mitochondria damage size.
Discussion
Despite significant effort, the role of RyR2 phospho-
rylation by PKA in the ‘fight or flight’ response and
pathophysiology of heart failure remains one of the most
noted controversies in the field. Marks and coworkers
have provided evidence in support of such a role via
phosphorylation on Ser-2808 increasing RyR2 activity
(Marx et al. 2000; Wehrens et al. 2006; Shan et al.
2010). Yet others found no indications that RyR2 PKA
phosphorylation perceptibly affected Ca2+ handling and
contractility in normal and diseased hearts (Li et al. 2002;
Xiao et al. 2005; Benkusky et al. 2007; Respress et al.
2012; Zhang et al. 2012); some studies even reported that
RyR2 dephosphorylation (rather than phosphorylation)
at this site increased RyR2 activity (Valdivia et al. 1995;
Terentyev et al. 2003). This long lasting controversy
is a likely indication that RyR2 regulation is more
complex than currently realized, thus resulting in a
range of apparently inconsistent results. In the pre-
sent study, we used a mouse model of Ca2+-dependent
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cardiomyopathy to examine the consequences of pre-
venting RyR2 phosphorylation at Ser-2808 on progression
of Ca2+-dependent disease. In this model, reduced
expression of the RyR2 stabilizing protein, CASQ2, is
combined with overexpression of SERCA1a to generate
sustained diastolic Ca2+ release. These mice died pre-
maturely, and displayed cardiac dysfunction and dilated
hypertrophy associated with enhanced diastolic Ca2+
release, Ca2+-dependent mitochondrial damage, and
myocyte death in a manner proportional to the extent
of diastolic release (Kalyanasundaram et al. 2012). In the
present study, using thismodel we found that inhibition of
RyR2 phosphorylation at Ser-2808, instead of alleviating,
exacerbated Ca2+ mishandling and cardiac dysfunction.
Notably, ablation of this site acted in a heterozygous
disadvantage manner, that is, the consequences of partial,
heterozygous ablation were more severe than those of
complete, homozygous ablation. These results do not
support the importance of RyR2 hyperphosphorylation
in Ca2+-dependent heart disease, and rather suggest roles
for the opposite process, the RyR2 dephosphorylation at
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this residue in physiological and pathophysiological Ca2+
signalling.
Mechanisms of action of constitutive
dephosphorylation of Ser-2808 in CCM
Consistent with previous studies (Carter et al. 2006;
Xiao et al. 2006; Benkusky et al. 2007), Ser-2808
phosphorylation was relatively high (75%) at baseline
condition in both WT and DM mice, even in the absence
of β-adrenergic stimulation (Fig. 6A). This is in sharp
contrast with the phosphorylation status of other sites
(e.g. Ser-2030 of RyR2, Ser-16 of PLB) that are low
at baseline and increase upon β-adrenergic stimulation
(Xiao et al. 2005; Benkusky et al. 2007). Therefore, to
account for the deterioration of the CCM phenotype in
TM mice, and in particular of those heterozygous for
S2808A, we hypothesized that dephosphorylation from
the more fully phosphorylated states at Ser-2808 makes
the RyR2 channels leakier, thereby exacerbating CCM. In
support of this hypothesis, application of PP1 produced
a surge in spark frequency in DM myocytes expressing
WT RyR2 highly phosphorylated at baseline, which was
absent in TM myocytes expressing RyR2s with fully or
partially disabled Ser-2808 phosphorylation sites (Fig. 6).
Interestingly, the increase in sparks in DM myocytes was
transient, consistentwith a transitionofRyR2s fromhighly
phosphorylated states to only partially dephosphorylated,
but functionallymore active states, and then to completely
dephosphorylated states with less pronounced leakiness
(Fig. 6). In further support of this explanation, the baseline
spark frequency for TMmyocytes was significantly higher
than that of DMmyocytes, with the difference being most
pronounced in the TM-S2808A+/−myocytes that mimic
partially dephosphorylated states (Fig. 6). Moreover,
[3H]ryanodine binding was significantly increased in
TM hearts, especially in the TM-S2808A+/− group,
which is indicative of increased RyR2 activity in these
groups (Fig. 7). These results are also supported by pre-
vious reports showing that RyR2 dephosphorylation can
increase RyR2 activity in various experimental settings
(Lokuta et al. 1995; Valdivia et al. 1995; Terentyev et al.
2003). The heterozygous-disadvantaged manner in which
genetic modification affected the RyR2 tetramer is not
unique to this channel. Similar effects have been reported
for a mutation in the HCN4 channel (Duhme et al. 2014),
which is also a tetramer. Apparently, partial modification
of tetramers alters monomer interaction, thus affecting
channel stability and functional activity (Duhme et al.
2014).
Notably, in addition to increased overall RyR2 leakiness
and mitochondrial damage, TM myocytes, particularly
those heterozygous for the S2808A modification,
exhibited profound heterogeneities in Ca2+ signalling
and regional mitochondrial degradation (‘Swiss cheese’
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pattern). These results suggest that the impact of increased
leakiness of dephosphorylated RyR2s in TM-S2808A+/−
myocytes is further amplified by heterogeneity of Ca2+
handling expected as a result of combinatorial variations
in the monomer composition of individual RyR2
tetramers. Indeed, the RyR2 channel is a protein tetramer
assembled from the available monomer variants (Nakai
et al. 1990; Fill & Copello, 2002); thus, in myocytes
expressing the two monomer variants, most channels
will be composed of a mixture of the phosphorylated
WT and non-phosphorylatable mutant monomers, with
a smaller fraction of channels composed of the WT or
mutant monomers only (i.e. 87.5%, 6.25% and 6.25%,
respectively; Xu et al. 2008; Loaiza et al. 2012). Our
results are consistent with other examples of degenerative
processes and localized Ca2+-dependent mitochondrial
damage caused by disruption in homogeneity of RyR2
function in both cardiac and skeletal muscle (Litwin et al.
2000; Diaz et al. 2002; Aistrup et al. 2006; Zhou et al.
2010).
When recently examining Ca2+ handling and RyR2
function in WT vs. S2808A mice, Ullrich et al. (2012)
found only subtle differences. However, these studies were
performed inmice homozygous for S2808A; furthermore,
most experiments were conducted in the presence of ISO,
which is expected to lead to RyR2 modifications through
other mechanisms, including CaMKII phosphorylation
at Ser-2814 and oxidation (Ferrero et al. 2007; Curran
et al. 2010; Bovo et al. 2012), thus masking potential
effects specifically related to the phosphorylation status
of Ser-2808. Therefore, future experiments are needed to
determine as to what extent this phenomenon applies to
other disease conditions and physiological settings.
Lastly, it is to be noted that survival of DM mice
in this study is substantially longer than what we
have previously reported in mice bearing the same
genetically-engineered modifications (Kalyanasundaram
et al. 2012). This difference could be ascribed to the
differences in the genetic background and gender of the
animals used as specified in the Methods. Genetic back-
ground and gender differences may also contribute, in
part, to the multiplicity of findings in the literature and
their role requires further investigation.
Implications for normal physiology and disease
Our study demonstrates an unexpected functional com-
plexity of RyR2 modification through phosphorylation/
dephosphorylation. Cardiac performance and Ca2+
handling are under balanced control of sympathetic and
parasympathetic systems. Upon sympathetic stimulation,
phosphorylation of RyR2 at Ser-2814 and other target
proteins including L-type Ca2+ channel and PLB
contributes to the ‘fight or flight’ response by facilitating
Ca2+ cycling (De Jongh et al. 1996; Chu et al. 2000; Pereira
et al. 2013). In contrast, Ser-2808 phosphorylation does
not seem to play a major role in this process. This is
supported by our results showing that ISO can facilitate
Ca2+ cycling independent of the S2808Amutation (Fig. 4).
Our investigation shed light on a novel mode of RyR2
operation, possibly evolved to mediate SR Ca2+ release at
low levels of cardiac energy consumption upon shifting
the regulatory balance to the parasympathetic side. The
dependence of Ca2+ release on SR Ca2+ content is highly
non-linear such that lowering SR Ca2+ content below a
level as high as 40% of normal can abolish release (Bassani
et al. 1995). Thus, increasing RyR2 activity through
dephosphorylation at Ser-2808, as shown here, coupled
with dephosphorylation of PLB and L-type Ca2+ channel
aimed at reducing the SR Ca2+ load could maximize
energy efficiency of Ca2+ cycling. In support of this
notion, ablation of the Ser-2808 phosphorylation sites
increased Ca2+ spark frequency not only in CCM myo-
cytes but also in myocytes from healthy SERCA1a over-
expression mice (Figs 5 and 6). Previously, it has been
suggested that reducingRyR2phosphorylationat Ser-2808
alleviates heart failure by decreasing SR Ca2+ leak. Our
results obtained in a genetic model of Ca2+-dependent
cardiomyopathy suggest that the relationship between
RyR2 phosphorylation/dephosphorylation at this site and
cardiac disease is much more complex and warrants
further investigation in clinically more relevant models.
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Translational perspective
The cardiac ryanodine receptor (RyR2) is the Ca2+ release channel of sarcoplasmic reticulum that
provides the Ca2+ necessary to induce cardiac contraction. Excessive RyR2 activity during diastole
(i.e. RyR2 Ca2+ leak) is thought to lead to a spectrum of cardiac pathologies (i.e. ‘ryanopathies’)
including heart failure (HF) by compromising systolic Ca2+ release and contractility, impairing
diastolic relaxation, and activating pathological hypertrophic pathways that trigger cell death.
Post-translational modifications of RyR2, especially phosphorylation, are considered among the
most important factors contributing to pathological RyR2 leakiness. However, the role of RyR2
phosphorylation in cardiac pathology remains incompletely understood and highly controversial.
Previouswork by some investigators has suggested that inHF, ‘hyperphosphorylation’ of RyR2 by PKA
at Ser-2808 renders RyR2 leaky, and that genetic ablation of Ser-2808 prevents RyR2 leakiness andHF.
However, these findings have not been reproduced by several other studies conducted in similar disease
settings. In our current study, we utilized a genetic model of cardiomyopathy induced by excessive
RyR2 Ca2+ leak. Remarkably, disabling Ser-2808 phosphorylation exacerbated rather than alleviated
Ca2+-dependent cardiomyopathy. Additionally, our results demonstrated that dephosphorylation,
rather than phosphorylation of Ser-2808 – a site that is already highly phosphorylated at baseline –
made RyR2 leakier and exacerbated the cardiomyopathy. Our results suggest that RyR2 modulation
by Ser-2808 phosphorylation is more complex than previously thought, thereby suggesting the need
for more tailored approaches in the design of HF therapies.
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